Massmutual Trust CO Fsb Cara Therapeutics, Inc. Transaction History

Massmutual Trust CO Fsb

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 06, 2023	SELL	$8.88 - $12.77 $692 - $996	-78 Reduced 41.94%	108 $1,000
Q3 2022 Oct 07, 2022	BUY	$8.24 - $12.56 $988 - $1,507	120 Added 181.82%	186 $2,000
Q2 2022 Jul 07, 2022	BUY	$7.45 - $13.84 $491 - $913	66 New	66 $1,000
Q1 2022 Apr 08, 2022	SELL	$9.94 - $12.65 $487 - $619	-49 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$11.99 - $18.14 $587 - $888	49 New	49 $1,000

Q4 2018 Feb 26, 2019	SELL	$12.45 - $23.47 $3,112 - $5,867	-250 Closed	0 $0
Q4 2017 Mar 01, 2018	SELL	$11.86 - $14.08 $46,443 - $55,137	-3,916 Reduced 94.0%	250 $3.06 Million
Q4 2017 Feb 21, 2018	BUY	$11.86 - $14.08 $46,443 - $55,137	3,916 Added 1566.4%	4,166 $775 Million
Q3 2017 Feb 13, 2018	BUY	$12.6 - $16.34 $1,260 - $1,634	100 Added 66.67%	250 $3.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	150	150 $2.31 Million

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.